Literature DB >> 343663

Immune response of ponies to experimental infection with Ehrlichia equi.

M B Nyindo, M Ristic, G E Lewis, D L Huxsoll, E H Stephenson.   

Abstract

Four ponies experimentally infected with Ehrlichia equi developed substantial cell-mediated immune responses, as measured by the leukocyte migration-inhibition test. Serum anti-E equi antibodies up to 1:1,280 were demonstrated by the indirect fluorescent antibody test. Cell-mediated immune responses returned to a base-line value by day 200 after primary inoculation, but serum antibody titers persisted for at least 300 days after inoculation. Two additional susceptible ponies, which were inoculated with convalescent blood or organ homogenates from ponies recovered from acute equine ehrlichiosis, treated with tetracycline, and subsequently challenge exposed with E equi-infective blood, did not develop clinical disease. This study suggested that ponies are resistant to reinfection with E equi following clinical ehrlichiosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343663

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  11 in total

Review 1.  An overview of research on ehrlichiosis.

Authors:  M Ristic; C J Holland; M Khondowe
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

2.  Cell mediated immunity to bovine rhinovirus type 1 in calves.

Authors:  A Hussain; S B Mohanty
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs.

Authors:  B Greig; K M Asanovich; P J Armstrong; J S Dumler
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island.

Authors:  M T Yeh; T N Mather; R T Coughlin; C Gingrich-Baker; J W Sumner; R F Massung
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Immunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila.

Authors:  M L Levin; D Fish
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Reinfection with Anaplasma phagocytophilum in BALB/c mice and cross-protection between two sympatric isolates.

Authors:  Michael L Levin; Dondrae J Coble; Danielle E Ross
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 7.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent).

Authors:  J E Barlough; J E Madigan; E DeRock; J S Dumler; J S Bakken
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  The effect of two different oxytetracycline treatments in experimental Ehrlichia phagocytophila infected lambs.

Authors:  S Stuen; K Bergström
Journal:  Acta Vet Scand       Date:  2001       Impact factor: 1.695

10.  Temporal and spatial variation in Anaplasma phagocytophilum infection in Swedish moose (Alces alces).

Authors:  J Malmsten; D Gavier Widén; G Rydevik; L Yon; M R Hutchings; C-G Thulin; L Söderquist; A Aspan; S Stuen; A-M Dalin
Journal:  Epidemiol Infect       Date:  2013-09-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.